Brugada syndrome and vasospasitc angina do coexist: Potential clinical importance

Internal Medicine

Volumn 45, Issue 2, 2006, Pages 43-44

  Aizawa, Yoshifusa ^a   Sato, Akinori ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Brugada syndrome; Calcium channel blocker; ST elevation; Vasospastic angina; Ventricular fibrillation

Indexed keywords

ANGINA PECTORIS; BRUGADA SYNDROME; COMORBIDITY; DEFIBRILLATOR; EDITORIAL; HEART ARREST; HUMAN; PREVALENCE; PRIMARY PREVENTION; TREATMENT INDICATION;

ACETYLCHOLINE; ANGINA PECTORIS; BUNDLE-BRANCH BLOCK; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CORONARY VASOSPASM; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL ISCHEMIA; SYNCOPE; VENTRICULAR FIBRILLATION;

EID: 33344458230     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.0138     Document Type: Editorial

References (17)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll
2. Yan GX, Antzelevitch C. Cellular bais for the Bruguda syndrome and other mechanism of arrthythmogenesis associated with ST-segment segment elevation. Circulation 100: 1660-1666, 1999.
3. Miyazaki T, Mitamura H, Miyoshi S. Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Bruguda syndrome. J Am Coll Cardiol 27: 1061-1070, 1996.
4. Yasue Y, Horio N, Nakamura N, et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina:possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 74: 955-963, 1986.
5. Igarashi Y, Tamura Y, Suzuki K, et al. Coronary artery spasm is a major cause of sudden cardiac arrest in survivors without underlying heart disease. Coron Artery Dis 4: 177-185, 1993.
6. Macalpin RN. Cardiac arrest and sudden unexpected death in variant angina: complications of coronary spasm that can occur in the absence of severe organic coronary stenois. Am Heart JV 125: 1011-1017, 1993.
7. Ito E, Suzuki K, Tanabe Y. A case of vasospastic angina presenting Bruguda-type ECG abnormalities. Jpn Circ J 63: 493-5, 1999.
8. Chinushi M, Kuroe Y, Ito E, Tagawa M, Aizawa Y. Vasospastic angina accompanied by Bruguda-type electrocardiographic abnormalities. J Cardiovasc Electrophysiol 12: 108-11, 2001.
9. Chinushi Y, Chinushi M, Toida T, Aizawa Y. Class I antiarrhythmic drug and coronary vasospasm-Induced T wave alternans and ventricular tachyarrhythmia in a patient with Bruguda Syndrome and vasospastic angina. J Cardiovascular Electrophysiology 13: 191-194, 200.
10. Imazio M, Ghisio A, Coda L, et al. Bruguda syndrome: a case report of an unusual association with vasospastic angina and coronary myocardial bridging. Pacing Clin Electrophysiol 25: 513-515, 2002.
11. Noda T, Shimizu W, Taguchi A, Satomi K, Suyama K, Kurita T, Aihara N, Kamakura S. ST-segment elevation and ventricular fibrillation without coronary spasm by intracoronary injection of acetycholine and/or ergonovine maleate in patients with Brugada syndrome. J Am Coll Cardiol 40: 1841-1847, 2002.
12. Chinushi M, Furushima H, Tanabe Y, Washizuka T, Aizawa Y. Similarities between Brugada syndrome and ischemia-induced ST-segement elevation. Clinical correlation and synergy. J Electrocardiol 38: 18-21, 2005.
13. Sasaki T, Niwano S. Kitano Y, Izumi T. Two cases of Brugada syndrome associated with spontaneous clinical episodes of coronary spasm. Intern Med 2005 45: 77-80, 2006.
14. Fish JM, Antzelevitch C. Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 1: 210-217, 2004.
15. Yasuda M, Nakazato Y, Sasaki A, et al. Ventricular fibrillation re-fractory to ICD therapy. Intern Med 44: 829-831, 2005.
16. Aizawa Y. Idiopathic ventricular fibrillation refractory to ICD therapy. Editorial. Intern Med 44: 778-779, 2005.
17. Aizawa Y, Chinushi M, Washizuka T. Indications for an implantable cardioverter-defibrillator (ICD). Intern Med 43: 360-367, 2004.